# Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)

> **NCT00067093** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1452 (actual)

## Conditions studied

- Deep Vein Thrombosis

## Interventions

- **DRUG:** SanOrg34006
- **DRUG:** LMW heparin
- **DRUG:** Unfractionated heparin
- **DRUG:** Vitamin K antagonist (VKA)

## Key facts

- **NCT ID:** NCT00067093
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 1452 (ACTUAL)
- **Last updated:** 2011-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067093, "Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00067093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*